Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics for I-131 and Hypothyroidism Side Effects
NCT03574051Phase 1Unknown
- Sponsor
- The First Affiliated Hospital of Harbin Medical University
- Start
- May 2018
- Primary completion
- May 2020
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, open-label trial of bifidobacterium infantis + lactobacillus acidophilus + enterococcus faecalis + bacillus cereus in hypothyroidism, sponsored by The First Affiliated Hospital of Harbin Medical University. Primary endpoint: Number of patients with improved side effects at 4 weeks. Status: unknown.
02
Drugs
bifidobacterium infantis + lactobacillus acidophilus + enterococcus faecalis + bacillus cereus
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on NCT03574051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03574051.